CFDB - Cystic Fibrosis DataBase

ongoing trials trial from other registries

Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients with Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas aeruginosa (PA)

Study design (if review, criteria of inclusion for studies)

Completed. Study results posted -

Participants

Male, Female:; Cystic fibrosis and new onset lower respiratory tract culture positive for Pseudomonas aeruginosa:

Interventions

Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI)

Keywords: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Colonization; Infection; Inhalation OR nebulised; pharmacological_intervention; Pseudomonas aeruginosa; Pseudomonas; Respiratory Tract Diseases; Respiratory Tract Infections; Monobactams; Powders;